AOD-9604
hGH fragment — targeted lipolysis without glucose impact
Where This Comes From
Full traceability from synthesis to your vial. No blind sourcing.
cGMP Synthesis
[cGMP Manufacturer — to be disclosed]
cGMP FacilityIndependent Testing
Analytika ISO Labs Inc. (ISO 17025 Accredited)
ISO 17025 LabBatch Released
Tested September 19, 2024 — all parameters pass.
COA PublishedWhat's in the Vial
Add bacteriostatic water slowly along the vial wall. Gently swirl to dissolve. Refrigerate at 2–8 °C; use within 28 days.
General Protocol Ranges
These are published research ranges — not a prescription. Your physician finalizes your protocol.
Research protocols typically dose 300–600 mcg per injection, once or twice daily before meals, for 12–16 week cycles. Subcutaneous injection in or near adipose tissue is standard.
Why Physician Oversight?
SourcePeptideCo does not dispense research-grade peptides without licensed physician oversight. This isn't a formality — these compounds interact with individual biochemistry in ways that require clinical judgment.
Our process: you submit a consultation intake, a coordinator matches you with a licensed physician in your state within one business day, and the physician designs a protocol appropriate to your research goals and health profile.
No physician sign-off, no order. That's the standard we hold to.
Request Consultation for AOD-9604 →Frequently Asked Questions
AOD-9604 is a C-terminal fragment of human growth hormone (residues 176–191) that retains the lipolytic domain but lacks the N-terminal binding region responsible for IGF-1 induction and glucose dysregulation. This makes it a more targeted compound for fat metabolism research.
Yes. Because AOD-9604 does not activate the growth hormone receptor in the same manner as intact hGH, it is not subject to the same regulatory scheduling in most jurisdictions — though this varies by country. Your physician will confirm applicable regulations for your jurisdiction.
Lyophilized peptide powder: store at −20 °C for long-term (up to 24 months) or at 4 °C for up to 6 months. Once reconstituted: refrigerate at 2–8 °C, use within the timeframe specified on your product (typically 14–30 days). Avoid repeated freeze-thaw cycles.
Our lyophilized peptides carry a 24-month expiry from manufacture date as printed on the batch label. Each COA confirms the exact lot date and expiry. Once reconstituted, shelf life drops significantly — see the reconstitution notes for your specific compound.
SourcePeptideCo operates through a licensed physician network. Peptide research compounds can interact with medications, contraindicate with certain conditions, and require clinical judgment for correct dosing. We don't sell without physician oversight — not as a formality, but because the oversight is part of the value.
A Certificate of Analysis (COA) documents the test results for a specific production batch. It certifies identity (the peptide is what we say it is), purity (by HPLC-UV), molecular mass (by LC-MS), endotoxin levels, and sterility. Every batch is tested by an independent ISO 17025-accredited laboratory.